Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 13 (3) , 257-267
- https://doi.org/10.3109/02652049609026014
Abstract
Sustained release biodegradable microcapsules of AZT were prepared using different concentrations of copolymer of poly(lactic/glycolic) acid (PLGA 50:50 and PLGA 90:10). Solid microcapsules were collected following the complete evaporation of the solvent. The yield of microcapsules was increased two fold with a two-fold increase of the polymer concentration. The efficiency of encapsulation of AZT was also increased with the increase of the polymer concentration. These microcapsules were characterized using scanning electron microscopy. The dissolution of AZT from the microcapsules of PLGA (50: 50) was higher than the microcapsules of PLGA (90:10); the PLGA (50:50) microcapsules containing 1:10 drug/polymer ratio showed higher dissolution than the microcapsules containing 1:20 drug/polymer ratio. The PLGA (90:10) microcapsules containing 1:6 drug/polymer ratio showed higher dissolution than the microcapsules containing 1:10 drug/polymer ratio. In conclusion, the dissolution of AZT was dependent on the type of the copolymer used and the relative concentrations of the drug and the copolymer.Keywords
This publication has 22 references indexed in Scilit:
- Formulation and Delivery of Proteins and PeptidesPublished by American Chemical Society (ACS) ,1994
- Determinants of Release Rate of Tetanus Vaccine from Polyester MicrospheresPharmaceutical Research, 1993
- Zidovudine (AZT) for Treatment of Patients Infected With Human Immunodeficiency Virus Type 1Archives of internal medicine (1960), 1991
- Microspheres and microcapsules, a survey of manufacturing techniques: Part III: Solvent evaporationPolymer Engineering & Science, 1990
- The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) InfectionAnnals of Internal Medicine, 1990
- Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapmentJournal of Microencapsulation, 1990
- Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1989
- Approval of Zidovudine (AZT) for Acquired Immunodeficiency SyndromeJAMA, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Developmental Therapeutics and the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1987